EUVIMEDEUVIMED entdecken
Crossref

Omeprazole. Do the dosage and duration of therapy matter?

Maria Janiak

Medycyna Faktów · 01.03.2026 · 19 (4(69)) · 514-518

DOI: 10.24292/01.mf.0425.05 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medycyna Faktów, online erschienen am 01.03.2026. Verfasst von Maria Janiak.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proton pump inhibitors (PPI) are the strongest medications used in the treatment of acid-dependent gastroenterology diseases that inhibit the secretion of hydrochloric acid in the stomach. One of the longest used and the best known proton pump inhibitor, since 1988, is omeprazol. The strength of the proton pump inhibitors is different in each patient and is caused by genetic conditions, metabolic differences dependent of cytochrome P450 (CYP) and also dependent on the type of acid inhibitor substance. The standard dose of proton pump inhibitors is dependent on the type of medication and is defined by their relative power, which is measured by time of pH maintain longer than 4 in 24 h. Selecting the appropriate omeprazol dose and duration of its use should be personalized and dependent on the indications of the therapy used.

Zitieren

APA

Janiak, M. (2026). Omeprazole. Do the dosage and duration of therapy matter?. Medycyna Faktów, 19(4(69)), 514-518. https://doi.org/10.24292/01.mf.0425.05

Vancouver

Janiak M. Omeprazole. Do the dosage and duration of therapy matter?. Medycyna Faktów. 2026;19(4(69)):514-518. doi:10.24292/01.mf.0425.05

BibTeX
@article{Janiak2026,
  author = {Janiak, Maria},
  title = {Omeprazole. Do the dosage and duration of therapy matter?},
  journal = {Medycyna Faktów},
  year = {2026},
  volume = {19},
  number = {4(69)},
  pages = {514--518},
  doi = {10.24292/01.mf.0425.05}
}
Kostenlos starten →